Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho(Memorial Sloan Kettering Cancer Center), James A. Fagin(Memorial Sloan Kettering Cancer Center), R. Michael Tuttle(Memorial Sloan Kettering Cancer Center), Ravinder K. Grewal, Somali Gavane, Steven M. Larson(Memorial Sloan Kettering Cancer Center), Julio C. Ricarte‐Filho, Rébecca Leboeuf(Centre Hospitalier de l’Université de Montréal), Désirèe Deandreis(Université Paris-Saclay), Pat Zanzonico(Memorial Sloan Kettering Cancer Center), Eric J. Sherman, Sofia Haque, Ronald Ghossein(Memorial Sloan Kettering Cancer Center), Ronglai Shen(Memorial Sloan Kettering Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Keith S. Pentlow, José Miguel Domínguez
Cited by 825
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k